136 related articles for article (PubMed ID: 16091363)
1. Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function.
Zhu Z; Ramos J; Kampa K; Adimoolam S; Sirisawad M; Yu Z; Chen D; Naumovski L; Lopez CD
J Biol Chem; 2005 Oct; 280(41):34473-80. PubMed ID: 16091363
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
[TBL] [Abstract][Full Text] [Related]
3. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
[TBL] [Abstract][Full Text] [Related]
4. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.
Nikrad M; Johnson T; Puthalalath H; Coultas L; Adams J; Kraft AS
Mol Cancer Ther; 2005 Mar; 4(3):443-9. PubMed ID: 15767553
[TBL] [Abstract][Full Text] [Related]
5. MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity.
Saha MN; Jiang H; Jayakar J; Reece D; Branch DR; Chang H
Cancer Biol Ther; 2010 Jun; 9(11):936-44. PubMed ID: 20418664
[TBL] [Abstract][Full Text] [Related]
6. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
[TBL] [Abstract][Full Text] [Related]
7. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
[TBL] [Abstract][Full Text] [Related]
8. The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib.
Yerlikaya A; Okur E; Ulukaya E
Tumour Biol; 2012 Oct; 33(5):1385-92. PubMed ID: 22477712
[TBL] [Abstract][Full Text] [Related]
9. Expression of heme oxygenase-1 in response to proteasomal inhibition.
Yerlikaya A
Protein Pept Lett; 2012 Dec; 19(12):1330-3. PubMed ID: 22670665
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
[TBL] [Abstract][Full Text] [Related]
11. Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
Bergamaschi D; Samuels Y; Zhong S; Lu X
Oncogene; 2005 May; 24(23):3836-41. PubMed ID: 15782125
[TBL] [Abstract][Full Text] [Related]
12. New insights into the expanding complexity of the tumor suppressor ASPP2.
Kampa KM; Bonin M; Lopez CD
Cell Cycle; 2009 Sep; 8(18):2871-6. PubMed ID: 19657229
[TBL] [Abstract][Full Text] [Related]
13. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
[TBL] [Abstract][Full Text] [Related]
14. Proapoptotic fibronectin fragment induces the degradation of ubiquitinated p53 via proteasomes in periodontal ligament cells.
Ghosh A; Joo NE; Chen TC; Kapila YL
J Periodontal Res; 2010 Aug; 45(4):481-7. PubMed ID: 20337881
[TBL] [Abstract][Full Text] [Related]
15. Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells.
Yu J; Tiwari S; Steiner P; Zhang L
Cancer Biol Ther; 2003; 2(6):694-9. PubMed ID: 14688479
[TBL] [Abstract][Full Text] [Related]
16. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P
J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells.
Ling YH; Liebes L; Zou Y; Perez-Soler R
J Biol Chem; 2003 Sep; 278(36):33714-23. PubMed ID: 12821677
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21.
Shen Y; Lu L; Xu J; Meng W; Qing Y; Liu Y; Zhang B; Hu H
Cell Biol Int; 2013 Oct; 37(10):1114-21. PubMed ID: 23716467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]